Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07199777
PHASE2
A Phase 2a Study to Evaluate the Safety, Tolerability, and Efficacy of SNP318 in DME Patients
Sponsor: SciNeuro
View on ClinicalTrials.gov
Summary
The objective of this study is to assess the safety, efficacy, and tolerability of SNP318 in patients with DME.
Official title: A Phase 2a, Randomized, Double-masked, Placebo-controlled, Multicenter Study to Evaluate the Safety, Tolerability, and Efficacy of SNP318 in Patients With Diabetic Macular Edema
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2025-11
Completion Date
2027-03
Last Updated
2025-09-30
Healthy Volunteers
No
Conditions
Interventions
DRUG
SNP318
Once daily, oral administration
DRUG
Placebo
Once daily, oral administration